The evaluation of clinical and prophylactic efficacy of the medicine Grippferon - nasal drops was performed at the leading research centers and institutions of practical health protection of Russia: Moscow - Tarasevich State Research Institute for Standardization and Control of Medicines, Central Research Institute of epidemiology HM RF; the Centre of State sanitary-and-epidemiologic supervision, Moscow; the Centre of State sanitary-and-epidemiologic supervision Moscow region RF; Moscow Region Research Institute (MONIKI); Saint-Petersburg Influenza Research Institute RAMS; Nizhniy Novgorod Nizhegorodskaya Medical Academy, Medical Service of Gorkiy Railway; Uljanovsk the Regional Children's Clinical Hospital; Jaroslavl State Medical Academy, Saratov State Medical University, Ukraine A.A. Bogomolets National Medical University, Kiev City Children's Clinical Hospital and other clinical institutions.

Clinical Investigations proved that Grippferon reduce the risk of contracting the airborne virus infections, including influenza, by 4-10 times. (Read more...)